Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (171-180 of 337) with videos related to

Pageof 34
Sort By:
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
HIV Medicine|March 19, 2024
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and UgandaTom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, et al.
The European Respiratory Journal|June 12, 2016
Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIVMarlanka A Zuur, Onno W Akkerman, Daan J Touw, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|May 12, 2016
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavirElise J Smolders, Clara T M M de Kanter, Karin Grintjes, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Pediatrics|August 8, 2002
Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavirAnnemarie M C van Rossum, Jeanne P Dieleman, Pieter L A Fraaij, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
AIDS (London, England)|June 6, 2008
Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medicationsCarolien J P Beukel van den Bout-van den, Marjolein E W Bosch, David M Burger, et al.
Pageof 34

Showing results (171-180 of 337) with videos related to

Sort By:
Pageof 34
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
HIV Medicine|March 19, 2024
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and UgandaTom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, et al.
The European Respiratory Journal|June 12, 2016
Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIVMarlanka A Zuur, Onno W Akkerman, Daan J Touw, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|May 12, 2016
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavirElise J Smolders, Clara T M M de Kanter, Karin Grintjes, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Pediatrics|August 8, 2002
Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavirAnnemarie M C van Rossum, Jeanne P Dieleman, Pieter L A Fraaij, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 2008
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individualsLaura Dickinson, Marta Boffito, David J Back, et al.
AIDS (London, England)|June 6, 2008
Toxic lopinavir concentrations in an HIV-1 infected patient taking herbal medicationsCarolien J P Beukel van den Bout-van den, Marjolein E W Bosch, David M Burger, et al.
Pageof 34